1. Home
  2. KNSA vs LTC Comparison

KNSA vs LTC Comparison

Compare KNSA & LTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • LTC
  • Stock Information
  • Founded
  • KNSA 2015
  • LTC 1992
  • Country
  • KNSA United Kingdom
  • LTC United States
  • Employees
  • KNSA N/A
  • LTC N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • LTC Real Estate Investment Trusts
  • Sector
  • KNSA Health Care
  • LTC Real Estate
  • Exchange
  • KNSA Nasdaq
  • LTC Nasdaq
  • Market Cap
  • KNSA 2.0B
  • LTC 1.6B
  • IPO Year
  • KNSA 2018
  • LTC 1992
  • Fundamental
  • Price
  • KNSA $26.03
  • LTC $35.90
  • Analyst Decision
  • KNSA Strong Buy
  • LTC Buy
  • Analyst Count
  • KNSA 6
  • LTC 4
  • Target Price
  • KNSA $38.00
  • LTC $38.25
  • AVG Volume (30 Days)
  • KNSA 677.6K
  • LTC 321.9K
  • Earning Date
  • KNSA 04-29-2025
  • LTC 05-05-2025
  • Dividend Yield
  • KNSA N/A
  • LTC 6.34%
  • EPS Growth
  • KNSA N/A
  • LTC 0.36
  • EPS
  • KNSA N/A
  • LTC 1.93
  • Revenue
  • KNSA $481,166,000.00
  • LTC $202,686,000.00
  • Revenue This Year
  • KNSA $37.21
  • LTC N/A
  • Revenue Next Year
  • KNSA $1.53
  • LTC $3.56
  • P/E Ratio
  • KNSA N/A
  • LTC $18.61
  • Revenue Growth
  • KNSA 59.45
  • LTC 3.98
  • 52 Week Low
  • KNSA $17.38
  • LTC $31.70
  • 52 Week High
  • KNSA $28.56
  • LTC $39.89
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 63.21
  • LTC 55.23
  • Support Level
  • KNSA $25.97
  • LTC $34.11
  • Resistance Level
  • KNSA $28.56
  • LTC $36.99
  • Average True Range (ATR)
  • KNSA 1.24
  • LTC 0.78
  • MACD
  • KNSA 0.36
  • LTC 0.05
  • Stochastic Oscillator
  • KNSA 71.70
  • LTC 62.15

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About LTC LTC Properties Inc.

LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in seniors housing and healthcare facilities through mortgage loans, property lease transactions, and other investments. Its real estate investments includes different types of properties such as Independent living communities, Assisted living communities, Memory care communities, Skilled nursing centers and other types of properties.

Share on Social Networks: